A detailed history of Creative Planning transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Creative Planning holds 1,632 shares of BIO stock, worth $539,979. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,632
Previous 1,539 6.04%
Holding current value
$539,979
Previous $420,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$263.97 - $344.64 $24,549 - $32,051
93 Added 6.04%
1,632 $546,000
Q2 2024

Aug 15, 2024

SELL
$268.26 - $339.48 $114,278 - $144,618
-426 Reduced 21.68%
1,539 $420,000
Q1 2024

May 10, 2024

BUY
$304.11 - $351.99 $17,638 - $20,415
58 Added 3.04%
1,965 $679,000
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $99,397 - $134,699
369 Added 23.99%
1,907 $615,000
Q3 2023

Nov 16, 2023

BUY
$350.25 - $422.63 $44,481 - $53,674
127 Added 9.0%
1,538 $551,000
Q2 2023

Jul 21, 2023

SELL
$359.49 - $486.4 $25,164 - $34,048
-70 Reduced 4.73%
1,411 $534,000
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $51,498 - $61,869
123 Added 9.06%
1,481 $709,000
Q4 2022

Feb 10, 2023

SELL
$351.71 - $456.01 $23,212 - $30,096
-66 Reduced 4.63%
1,358 $571,000
Q3 2022

Nov 03, 2022

BUY
$412.59 - $563.26 $101,909 - $139,125
247 Added 20.99%
1,424 $594,000
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $44,512 - $57,327
96 Added 8.88%
1,177 $583,000
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $524 - $735
1 Added 0.09%
1,081 $609,000
Q3 2021

Nov 10, 2021

BUY
$657.71 - $825.77 $14,469 - $18,166
22 Added 2.08%
1,080 $806,000
Q2 2021

Aug 04, 2021

SELL
$576.64 - $649.04 $12,109 - $13,629
-21 Reduced 1.95%
1,058 $682,000
Q1 2021

Apr 30, 2021

BUY
$547.01 - $662.35 $259,829 - $314,616
475 Added 78.64%
1,079 $616,000
Q4 2020

Jan 29, 2021

BUY
$510.68 - $643.45 $29,619 - $37,320
58 Added 10.62%
604 $352,000
Q3 2020

Nov 05, 2020

BUY
$454.43 - $535.6 $4,089 - $4,820
9 Added 1.68%
546 $281,000
Q2 2020

Jul 23, 2020

BUY
$334.87 - $493.06 $179,825 - $264,773
537 New
537 $242,000
Q1 2020

May 05, 2020

SELL
$320.01 - $409.07 $371,531 - $474,930
-1,161 Closed
0 $0
Q4 2019

Jan 30, 2020

BUY
$319.73 - $374.2 $137,164 - $160,531
429 Added 58.61%
1,161 $430,000
Q3 2019

Nov 01, 2019

BUY
$304.55 - $345.24 $6,395 - $7,250
21 Added 2.95%
732 $244,000
Q2 2019

Jul 26, 2019

SELL
$286.93 - $312.59 $3,443 - $3,751
-12 Reduced 1.66%
711 $222,000
Q1 2019

Apr 24, 2019

SELL
$224.3 - $317.41 $48,897 - $69,195
-218 Reduced 23.17%
723 $221,000
Q4 2018

Feb 01, 2019

SELL
$220.1 - $309.0 $97,944 - $137,505
-445 Reduced 32.11%
941 $219,000
Q3 2018

Oct 25, 2018

SELL
$289.28 - $326.15 $27,192 - $30,658
-94 Reduced 6.35%
1,386 $434,000
Q2 2018

Jul 20, 2018

BUY
$244.1 - $303.88 $1,708 - $2,127
7 Added 0.48%
1,480 $427,000
Q1 2018

Apr 18, 2018

SELL
$233.97 - $274.11 $20,121 - $23,573
-86 Reduced 5.52%
1,473 $368,000
Q4 2017

Jan 17, 2018

BUY
$216.94 - $271.3 $216 - $271
1 Added 0.06%
1,559 $372,000
Q3 2017

Oct 17, 2017

BUY
$212.27 - $242.28 $330,716 - $377,472
1,558
1,558 $346,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.15B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.